China Pharma Holdings (CPHI) Price to Book (2010 - 2026)

China Pharma Holdings (CPHI) has reported Price to Book for 17 consecutive years, with 0.74 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 18.2% year-over-year to 0.74; the trailing twelve-month figure through Jun 2026 stood at 0.74 (down 18.2% YoY), and the FY2025 full-year result was 0.23, down 56.43% from the prior year.
• Price to Book advanced to 0.74 in Q2 2026 per CPHI's latest filing, from 0.42 in the prior quarter.
• Across five years, Price to Book topped out at 3.53 in Q1 2022 and bottomed at 0.23 in Q4 2025.
• Historically, Price to Book has averaged 1.03 across 5 years, with a median of 0.68 in 2023.
• The sharpest annual moves came in 2023 and 2024: Price to Book plunged 86.16% in 2023, then soared 101.96% in 2024.
• Over 5 years, Price to Book stood at 1.18 in 2022, then sank by 76.63% to 0.27 in 2023, then jumped by 90.84% to 0.52 in 2024, then plunged by 56.43% to 0.23 in 2025, then soared by 223.71% to 0.74 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 0.74, 0.42, and 0.23 for Q2 2026, Q1 2026, and Q4 2025 respectively.